• Ethan Waisberg, Joshua Ong, Nasif Zaman, Sharif Amit Kamran, Alireza Tavakkoli, and Andrew G Lee.
• University College Dublin School of Medicine, Belfield, Dublin 4, Ireland. ethan.waisberg@ucdconnect.ie.
• Ir J Med Sci. 2023 Dec 1; 192 (6): 310131033101-3103.

BackgroundAnecdotally, the COVID-19 pandemic has resulted in more severe cases of eye disease, decreased medication compliance/availability, and decreased treatment volume due to the lockdown.AimsWe aim to quantify and bring together a variety of international perspectives from ophthalmologists of different subspecialties to characterize the global impact of COVID-19 on managing various ophthalmic disease.MethodsAn online survey of 10 questions was conducted among ophthalmologists using a specialized survey program.ResultsFifty-two ophthalmologists were successfully contacted. Survey respondents include ophthalmologists from USA, Canada, Korea, Mexico, and New Zealand. Based on the results of our survey, 1 year after the pandemic, ophthalmic disease severity has worsened as well as a decrease in examination and medication compliance.ConclusionsOphthalmologists across the world have reported a general increase in disease severity and decrease in medication and examination compliance 1 year after the beginning of COVID-19.© 2023. The Author(s).

12 keywords...

hide…